Zode Gulab S, Sethi Anirudh, Brun-Zinkernagel Anne-Marie, Chang I-Fen, Clark Abbot F, Wordinger Robert J
Department of Cell Biology and Genetics, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX 76107, USA.
Mol Vis. 2011;17:1745-58. Epub 2011 Jun 28.
Transforming growth factor-β2 (TGF-β2) is associated with glaucomatous neuropathy, primarily via the increased synthesis and secretion of extracellular matrix (ECM) proteins and remodeling of the optic nerve head (ONH). Here, we investigated the signaling pathways used by TGF-β2 to stimulate ECM expression by ONH astrocytes and lamina cribrosa (LC) cells.
TGF-β2 localization and secretion was examined in human donor tissues and ONH astrocytes and LC cells. To examine TGF-β2 signaling, ONH astrocytes and LC cells were treated with recombinant TGF-β2, and phosphorylation of Smad and non-Smad signaling proteins were examined by western blot analyses and immunostaining.
TGF-β2 is significantly increased in the LC region of the ONH in glaucomatous eyes compared to age-matched normal eyes (n=4, p<0.0013). ONH astrocytes and LC cells secrete TGF-β2, indicating that these cells may be an in vivo source of TGF-β2 in the human ONH. In addition, treatment of ONH astrocytes and LC cells with exogenous TGF-β2 increased ECM protein synthesis and secretion. With respect to TGF-β2 signaling, recombinant TGF-β2 induced phosphorylation of canonical signaling proteins Smad2/3 but did not alter phosphorylation of non-canonical signaling proteins extracellular signal-regulated kinases (ERK)1/2, p38, and c-Jun N-terminal kinases (JNK)1/2 proteins in ONH astrocytes and LC cells. Exogenous TGF-β2 increased co-localization of pSmad2/3 with Co-Smad4 in the nucleus of ONH astrocytes and LC cells further indicating activation of the canonical Smad signaling pathway. Furthermore, inhibition of TGF-β I receptor activity by SB431542 or inhibition of Smad3 phosphorylation by SIS3 blocked TGF-β2 stimulated ECM expression as well as activation of downstream canonical pathway signaling molecules. Knockdown of either Smad2 or Smad3 via small interfering RNA (siRNA) reduced TGF-β2 stimulated ECM proteins in ONH astrocytes and LC cells.
These studies indicate that TGF-β2 utilizes the canonical Smad signaling pathway to stimulate ECM synthesis in human ONH cells. Our studies also indicate that pSmad2/3 is required for TGF-β2 stimulation of ECM remodeling.
转化生长因子-β2(TGF-β2)与青光眼性神经病变相关,主要是通过细胞外基质(ECM)蛋白合成和分泌增加以及视神经乳头(ONH)重塑。在此,我们研究了TGF-β2用于刺激ONH星形胶质细胞和筛板(LC)细胞表达ECM的信号通路。
在人供体组织以及ONH星形胶质细胞和LC细胞中检测TGF-β2的定位和分泌。为了检测TGF-β2信号,用重组TGF-β2处理ONH星形胶质细胞和LC细胞,并通过蛋白质印迹分析和免疫染色检测Smad和非Smad信号蛋白的磷酸化。
与年龄匹配的正常眼睛相比,青光眼患者眼睛的ONH的LC区域中TGF-β2显著增加(n = 4,p < 0.0013)。ONH星形胶质细胞和LC细胞分泌TGF-β2,表明这些细胞可能是人类ONH中TGF-β2的体内来源。此外,用外源性TGF-β2处理ONH星形胶质细胞和LC细胞可增加ECM蛋白的合成和分泌。关于TGF-β2信号,重组TGF-β2诱导经典信号蛋白Smad2/3磷酸化,但未改变ONH星形胶质细胞和LC细胞中非经典信号蛋白细胞外信号调节激酶(ERK)1/2、p38和c-Jun氨基末端激酶(JNK)1/2蛋白的磷酸化。外源性TGF-β2增加了pSmad2/3与Co-Smad4在ONH星形胶质细胞和LC细胞核中的共定位,进一步表明经典Smad信号通路的激活。此外,SB431542抑制TGF-β I受体活性或SIS3抑制Smad3磷酸化可阻断TGF-β2刺激的ECM表达以及下游经典通路信号分子的激活。通过小干扰RNA(siRNA)敲低Smad2或Smad3可降低TGF-β2刺激的ONH星形胶质细胞和LC细胞中的ECM蛋白。
这些研究表明,TGF-β2利用经典Smad信号通路刺激人ONH细胞中的ECM合成。我们的研究还表明,pSmad2/3是TGF-β2刺激ECM重塑所必需的。